Detalhe da pesquisa
1.
Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement.
Cancer Immunol Immunother
; 71(2): 289-300, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34142235
2.
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.
Cancer Immunol Res
; 12(3): 334-349, 2024 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194598
3.
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors.
Nat Commun
; 15(1): 48, 2024 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167722
4.
Intertumoral Differences Dictate the Outcome of TGF-ß Blockade on the Efficacy of Viro-Immunotherapy.
Cancer Res Commun
; 3(2): 325-337, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36860656
5.
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy.
J Immunother Cancer
; 10(7)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853671
6.
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S.
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35264435